Futr Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Futr Bio General Information

Description

Developer of a vaccine platform designed to prevent and cure infectious diseases and cancer. The company offers technology that incorporates natural untranslated regions and molecular boosters to provide immune responses, enabling healthcare providers to access single-dose vaccines that induce efficient, regulated, and durable protection for humans and animals.

Contact Information

Website
www.futr.bio
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Espaço + Um Rod. José Carlos Daux, 6977
  • Santo Antônio de Lisboa
  • Florianópolis, Santa Catarina 88050-000
  • Brazil
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • Espaço + Um Rod. José Carlos Daux, 6977
  • Santo Antônio de Lisboa
  • Florianópolis, Santa Catarina 88050-000
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Futr Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 12-Feb-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Futr Bio’s complete valuation and funding history, request access »

Futr Bio Patents

Futr Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4482520-A1 Next generation mrna vaccines Pending 22-Feb-2022
US-20250090648-A1 Next generation mrna vaccines Pending 22-Feb-2022
WO-2023161715-A1 Next generation mrna vaccines Inactive 22-Feb-2022 A61K39/12

Futr Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Futr Bio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Vesper (Biotechnology) Accelerator/Incubator Minority
Biominas Brasil Accelerator/Incubator
To view Futr Bio’s complete investors history, request access »

Futr Bio FAQs

  • When was Futr Bio founded?

    Futr Bio was founded in 2022.

  • Where is Futr Bio headquartered?

    Futr Bio is headquartered in Florianópolis, Brazil.

  • What is the size of Futr Bio?

    Futr Bio has 3 total employees.

  • What industry is Futr Bio in?

    Futr Bio’s primary industry is Drug Discovery.

  • Is Futr Bio a private or public company?

    Futr Bio is a Private company.

  • What is Futr Bio’s current revenue?

    The current revenue for Futr Bio is .

  • Who are Futr Bio’s investors?

    Vesper (Biotechnology) and Biominas Brasil have invested in Futr Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process